United States

People in the US Receiving Mental Health Services Who Have a Co-Occurring Substance Use Disorder, by Diagnosis

"In the 2015 reporting period, mental health diagnoses among individuals served who had co-occurring mental health and substance use disorders differed very little by substance use diagnosis. (Unlike mental health diagnoses, where up to three diagnoses are recorded per client record, each client record contains only one substance use diagnosis. See the final section of Appendix E for definitions of substance abuse codes.)

"• Bipolar disorders were the most frequently reported mental health diagnoses for individuals served who had co-occurring marijuana dependence (29 percent).

People in the US Receiving Mental Health Services Who Have a Co-Occurring Substance Use Disorder, by Age and Gender

"For the 2015 reporting period, states reported a total of 720,987 individuals served aged 12 and older (14 percent of all individuals served) had co-occurring mental health and substance use disorders.

"During this period, the data show that mental health diagnoses differed somewhat across categories for several variables, including gender, age group, race, ethnicity, living arrangements, employment and detailed “not in labor force,” service setting, and timing of admission. Mental health diagnoses were largely similar across SMI/SED status and level of functioning.

Mental Health Treatment Admissions, Discharges, and Client Outcomes

"In the 2015 reporting period, six states and jurisdictions (Connecticut [adults only], the District of Columbia, Louisiana, Mississippi, Oklahoma, and Puerto Rico) reported a total of 417,443 admissions to MH-TEDS [Mental Health Treatment Episode Data Set]. [Table 7.1]:

"• Of admissions who began treatment prior to the 2015 reporting period, 69 percent of admissions received treatment in community programs, 57 percent in residential treatment centers, 43 percent in state psychiatric hospitals, and 31 percent in institutions under the justice system [Table 7.1].

People with Co-occurring Mental Health and Substance Use Disorders Receiving Mental Health Services

"A total of 720,987 individuals aged 12 and older with co-occurring mental health and substance use disorders were served in 2015 [Table 6.1a].

"• Among males who had co-occurring mental health and substance use disorders served in the 2015 reporting period, the most frequently reported diagnoses were depressive disorders and schizophrenia and other psychotic disorders (25 percent each); for females, they were depressive disorders (33 percent) [Table 6.1c].

People Receiving Mental Health Services in the United States

"For the 2012 reporting period, 32 states and jurisdictions reported that a total of 3,126,234 individuals had received mental health services; for the 2015 reporting period, 45 states and jurisdictions reported that a total of 5,235,883 individuals had received mental health services [Table 1.1].

"• More than 50 percent of the total individuals served were female in every reporting period between 2012 and 2015 [Table 1.2a].

Impact of Medical Marijuana Laws on Marijuana Use by Young People

"In summary, current evidence does not support the hypothesis that MML passage is associated with increased marijuana use prevalence among adolescents in states that have passed such laws up until 2014. Based on this evidence, we recommend several steps to advance the understanding of current and future marijuana policy effects. First, continued exploration of the effects of these state policies on different measures of use among adolescents is warranted.

Extended Release Injectable Naltrexone (Vivitrol)

"What is VIVITROL?
"VIVITROL is a prescription injectable medicine used to:
"• treat alcohol dependence. You should stop drinking before starting VIVITROL.
"• prevent relapse to opioid dependence, after opioid detoxification.
"This means that if you take opioids or opioid-containing medicines, you must stop taking them before you start receiving VIVITROL. See “What is the most important information I should know about VIVITROL?”

Likelihood That Young People with Diagnosed Mental Health Conditions Will be Put on Long Term Opioid Therapy

"Of the 1,000,453 opioid recipients (81.7%) with at least 6 months of follow-up, 51.1% were female, and the median age was 17 years (interquartile range, 16-18 years). Among these adolescents, the estimated cumulative incidence of LTOT [Long Term Opioid Therapy] after first opioid receipt was 1.1 (95% CI, 1.1-1.2) per 1000 recipients within 1 year, 3.0 (95% CI, 2.8-3.1) per 1000 recipients within 3 years, 8.2 (95% CI, 7.8-8.6) per 1000 recipients within 6 years, and 16.1 (95% CI, 14.2-18.0) per 1000 recipients within 10 years.

Pages